In bone sarcoma cell lines, drug/protein associations included a strong association of protein abundance of peptidyl-prolyl cis-trans isomerase H (PPIH) with response to the Aurora kinase B/C selective inhibitor GSK1070916. Here, PPIH is linked to bone sarcoma.